OncoVex GM-CSF: BioVex began a U.K. Phase I trial in 18 patients with solid tumors.

BioVex Ltd., Oxford, U.K.
Product: OncoVex

Read the full 60 word article

How to gain access

Continue reading with a
two-week free trial.